MALAT1 has been demonstrated to be abnormally regulated and exhibits prognostic significance in several cancers, including hepatocellular carcinoma, breast cancer, colorectal cancer, and gastric cancer as well as esophageal cancer 7-9. Here, MALAT1 is linked to esophageal cancer.